Suven Pharmaceuticals Ltd reports higher consolidated PAT of Rs. 105.08 crores in Q1FY22

SUVEN PHARMACEUTICALS LIMITED has reported financial results for the period ended June 30, 2021.

Financial Results (Q1 FY 2021-22) - QoQ Comparison

The company has reported total income of Rs.269.58 crores during the period ended June 30, 2021 as compared to Rs.262.46 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.105.08 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.83.11 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.4.13 for the period ended June 30, 2021 as compared to Rs.3.27 for the period ended March 31, 2021.

Financials	Q1 FY2021-22	Q4 FY20-21	% Change
Total Income	₹ 269.58 crs	₹ 262.46 crs	2.71%
Net Profit	₹ 105.08 crs	₹ 83.11 crs	26.43%
EPS	₹ 4.13	₹ 3.27	26.3%

Financial Results (Q1 FY 2021-22) - YoY Comparison

The company has reported total income of Rs.269.58 crores during the period ended June 30, 2021 as compared to Rs.243.97 crores during the period ended June 30, 2020.

The company has posted net profit / (loss) of Rs.105.08 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.91.52 crores for the period ended June 30, 2020.

The company has reported EPS of Rs.4.13 for the period ended June 30, 2021 as compared to Rs.3.60 for the period ended June 30, 2020.

Financials	Q1 FY2021-22	Q1 FY2020-21	% Change
Total Income	₹ 269.58 crs	₹ 243.97 crs	10.5%
Net Profit	₹ 105.08 crs	₹ 91.52 crs	14.82%
EPS	₹ 4.13	₹ 3.60	14.72%

Shares of SUVEN PHARMACEUTICALS LIMITED was last trading in BSE at Rs. 537.1 as compared to the previous close of Rs. 542.4. The total number of shares traded during the day was 33871 in over 2065 trades.

The stock hit an intraday high of Rs. 549.15 and intraday low of 512.15. The net turnover during the day was Rs. 18165418.

Source : Equity Bulls

Keywords